A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: unbiased (1), impartial (11), pale (37)

Cyclophosphamide-Doxorubicin-Paclitaxel

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN-PACLITAXEL (21 day) Regimen • Breast Cancer – Cyclophosphamide-Doxorubicin-Paclitaxel (
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Paclitaxel.pdf

Cyclophosphamide-Docetaxel-Doxorubicin Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-DOXORUBICIN Regimen (TAC) Breast Cancer – Cyclophosphamide-Docetaxel-Doxorubicin (TAC) Indication Adjuvant
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelDoxorubicinTACVer11.pdf

Cyclophosphamide-Docetaxel Ver 1.1

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL Regimen Breast Cancer – Cyclophosphamide-Docetaxel Indication Adjuvant therapy for ear
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelVer11.pdf

DA_3+8

Description
Regimen Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (3+8)–Cytarabine-Daunorubicin In-Patient Regimen • Acute Myeloid Leukaemia – InP-DA (3+8)–Cytarabine-Daunorubicin Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-3-8.pdf

DA_2+5

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA DA (2 + 5) – Cytarabine-Daunorubicin In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-DA (2+5)–Cytarabine-Daunorubicin Indicat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/DA-2-5.pdf

Capecitabine-Gemcitabine

Description
Chemotherapy Protocol PANCREATIC CANCER CAPECITABINE and GEMCITABINE Regimen • Pancreatic Cancer– Capecitabine-Gemcitabine Indication • Adjuvant treatment of pancre
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Capecitabine-Gemcitabine.pdf

Fluorouracil-FolinicAcid(MdG)-Oxaliplatin-Panitumumab

Description
Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL, FOLINIC ACID (Modified de Gramont), OXALIPLATIN and PANITUMUMAB (FOLFOX-Panitumumab) Regimen • Colorectal Cancer– Fluorouracil, Folinic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-FolinicAcidMdG-Oxaliplatin-Panitumumab.pdf

Fluorouracil-Folinic acid(MdG)-Irinotecan-Panitumumab

Description
Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL, FOLINIC ACID (Modified de Gramont), IRINOTECAN and PANITUMUMAB (FOLFIRI-Panitumumab) This protocol may require funding Regimen • Colo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Folinic-acidMdG-Irinotecan-Panitumumab.pdf

Cetuximab-Irinotecan (14 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-IRINOTECAN (14 day) This regimen may require funding Regimen • Colorectal Cancer–Cetuximab-Irinotecan (14 day) I
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Irinotecan14day.pdf

Cetuximab (7 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB (7 day) This regimen may require funding Regimen • Colorectal Cancer – Cetuximab (7 day) Indication • Metastatic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab7day.pdf
161 to 170 of 265
Previous … 15 16 17 18 19 … Next